Skip to main content

Peer Review reports

From: The timing of durvalumab administration affects the risk of pneumonitis in patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis

Original Submission
5 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 Jul 2023 Reviewed Reviewer Report
31 Jul 2023 Reviewed Reviewer Report
10 Sep 2023 Author responded Author comments - Chunli Wu
Resubmission - Version 3
10 Sep 2023 Submitted Manuscript version 3
11 Sep 2023 Author responded Author comments - Chunli Wu
Resubmission - Version 4
11 Sep 2023 Submitted Manuscript version 4
Publishing
3 Oct 2023 Editorially accepted
10 Oct 2023 Article published 10.1186/s12885-023-11472-3

You can find further information about peer review here.

Back to article page